Efraim Idelevich

Summary

Country: Israel

Publications

  1. ncbi request reprint Irinotecan combined with bolus 5-fluorouracil and folinic acid for metastatic colorectal cancer: is this really a dangerous treatment?
    E Idelevich
    Institute of Oncology Kaplan Medical Center, Rehovot, Israel
    J Chemother 16:487-90. 2004
  2. ncbi request reprint Small bowel obstruction caused by secondary tumors
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Surg Oncol 15:29-32. 2006
  3. doi request reprint Prospective phase II study of neoadjuvant therapy with cisplatin, 5-fluorouracil, and bevacizumab for locally advanced resectable esophageal cancer
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Onkologie 35:427-31. 2012
  4. pmc Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study
    Yulia Kundel
    Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Radiat Oncol 6:127. 2011
  5. doi request reprint Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Chemotherapy 55:76-82. 2009
  6. ncbi request reprint Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer
    Efraim Idelevich
    Kaplan Medical Center, Rehovot, Israel
    Acta Oncol 46:324-9. 2007
  7. doi request reprint Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Onkologie 31:673-7. 2008
  8. pmc Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study
    Natalia Goldberg
    Institute of Oncology, Beilinson Hospital, Petah Tiqva, Israel
    Radiat Oncol 7:124. 2012
  9. ncbi request reprint One hundred transhiatal esophagectomies: a single-institution experience
    Guy Pines
    Department of Surgery B, Kaplan Medical Center, Rehovot, affiliated with Hebrew University Hadassah Medical School, Jerusalem, Israel
    Isr Med Assoc J 13:428-33. 2011
  10. doi request reprint Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?
    Yulia Kundel
    Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel
    Dis Colon Rectum 53:1624-31. 2010

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Irinotecan combined with bolus 5-fluorouracil and folinic acid for metastatic colorectal cancer: is this really a dangerous treatment?
    E Idelevich
    Institute of Oncology Kaplan Medical Center, Rehovot, Israel
    J Chemother 16:487-90. 2004
    ..In our experience this regimen has manageable toxicity and appropriate level of dose intensity and seems to be a good option for first-line therapy in metastatic colorectal cancer...
  2. ncbi request reprint Small bowel obstruction caused by secondary tumors
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Surg Oncol 15:29-32. 2006
    ..The goal of this article is to define current knowledge on this phenomenon, with emphasis on its epidemiology and clinical characteristics, and to increase the awareness of the clinician treating cancer patients of such possibility...
  3. doi request reprint Prospective phase II study of neoadjuvant therapy with cisplatin, 5-fluorouracil, and bevacizumab for locally advanced resectable esophageal cancer
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Onkologie 35:427-31. 2012
    ..We investigated the efficacy and tolerability of cisplatin and 5-fluorouracil (5-FU) plus bevacizumab as neoadjuvant therapy for patients with locally advanced resectable esophageal cancer...
  4. pmc Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study
    Yulia Kundel
    Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Radiat Oncol 6:127. 2011
    ..As we did not expect a different toxic profile in patients (pts) with positive margins (R1 resection), these were studied together with pts after complete resection (R0)...
  5. doi request reprint Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Chemotherapy 55:76-82. 2009
    ..Compared with systemic therapy, hepatic arterial infusion (HAI) increases the response to fluoropyrimidines...
  6. ncbi request reprint Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer
    Efraim Idelevich
    Kaplan Medical Center, Rehovot, Israel
    Acta Oncol 46:324-9. 2007
    ..The combination of cisplatin, epirubicin, UFT, and leucovorin has significant activity and tolerable toxicities in patients with MGC and represents a convenient treatment option for these patients...
  7. doi request reprint Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience
    Efraim Idelevich
    Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
    Onkologie 31:673-7. 2008
    ..The survival benefit of neoadjuvant chemotherapy in patients undergoing surgery for esophageal cancer is unclear...
  8. pmc Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study
    Natalia Goldberg
    Institute of Oncology, Beilinson Hospital, Petah Tiqva, Israel
    Radiat Oncol 7:124. 2012
    ..This prospective study evaluated the ability of a very early metabolic response, seen after only one week of RCT, to predict the histopathological response to treatment...
  9. ncbi request reprint One hundred transhiatal esophagectomies: a single-institution experience
    Guy Pines
    Department of Surgery B, Kaplan Medical Center, Rehovot, affiliated with Hebrew University Hadassah Medical School, Jerusalem, Israel
    Isr Med Assoc J 13:428-33. 2011
    ..Transhiatal esophagectomy with cervical esophagogastric anastomosis is considered relatively safe with an oncological outcome comparable to that using the transthoracic approach...
  10. doi request reprint Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?
    Yulia Kundel
    Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel
    Dis Colon Rectum 53:1624-31. 2010
    ....
  11. doi request reprint Disease-related mortality within the first year after subtotal esophagectomy for cancer
    Guy Pines
    Department of Surgery B, Kaplan Medical Center, Rehovot, Israel
    Ann Surg Oncol 18:1139-44. 2011
    ..The mortality rate within the first year after surgery is unknown, but identifying risk factors for early mortality would increase our ability to predict the outcome of these patients and might improve patient selection...
  12. ncbi request reprint Endoscopic ultrasound: doubtful accuracy for restaging esophageal cancer after preoperative chemotherapy
    Svetlana Machlenkin
    Department of Surgery, Kaplan Medical Center and Hebrew University Hadassah Medical School, Rehovot, Israel
    Isr Med Assoc J 11:166-9. 2009
    ..The role of endoscopic ultrasound in evaluating the response of esophageal cancer to neoadjuvant chemotherapy is controversial...
  13. ncbi request reprint Oncogenes in male breast cancer
    Efraim Idelevich
    Institutes of Oncology, Kaplan Medical Center, Rehovot, Israel
    Am J Clin Oncol 26:259-61. 2003
    ..At present there is inadequate evidence to support the use of molecular markers as independent prognostic markers in MBC...
  14. ncbi request reprint Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews
    Baruch Brenner
    Institute of Oncology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Cancer 94:2128-33. 2002
    ..Because Ashkenazi Jews comprise one of the major ethnic groups in Israel, the authors conducted a local study to shed more light on the features of this rare disease...
  15. ncbi request reprint Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil
    Rinat Yerushalmi
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Surg Oncol 93:529-33. 2006
    ..We compared the efficacy and toxicity of oral capecitabine and continuous infusion of 5-fluorouracil (5-FU) in the preoperative chemoradiation treatment of patients with rectal cancer...